@jmbarrhaven
The advice from the second oncologist seems in line with my own experience getting tested. For me it was needed to qualify me for a clinical trial. I recall my own oncologist suggesting there were lots more out there with the HRD and knowing that would help them when prescribing treatment or considering trial candidates but that up until then (which was two years ago) the testing was not done routine. Unlike with the original approval for use of Olaprib, Zejula's sister drug, where you had to be BRCA positive, I've never heard of any prerequisite genetically related to Zejula. So at a loss for what your oncologist is suggesting.
Any of our current community been told anything similar to what jmbarrhaven has? Please comment if you have.